Foley Hoag Leads The Gambia’s Legal Team in Historic Case to Stop Myanmar’s Genocide Against the Rohingya
The Gambia, acting on behalf of the 57 Member States of the Organization of Islamic Cooperation, today filed a historic lawsuit in the International Court of Justice, in The Hague, seeking to hold Myanmar accountable under international law for State-sponsored genocide against its minority Muslim population, known as the Rohingya. The suit also asks the Court to order Myanmar to cease and desist from all acts of genocide, to punish those responsible, including senior government officials and military officers, and to make reparations to the victims.
The suit requests, as a matter of extreme urgency, that the Court order “Provisional Measures” to stop Myanmar’s genocidal conduct immediately, in order to prevent further harm to the Rohingya people while the case is pending. The Court is expected to hold oral hearings on this request next month.
The suit alleges that Myanmar’s actions, “which include killing, causing serious bodily and mental harm, inflicting conditions that are calculated to bring about physical destruction, imposing measures to prevent births, and forcible transfers, are genocidal in character because they are intended to destroy the Rohingya group in whole or in part.” These genocidal acts are documented extensively by independent investigative efforts undertaken by United Nations experts and bodies, including the UN Human Rights Council’s Independent International Fact-Finding Mission on Myanmar, and have been corroborated by international human rights organizations and other credible sources.
The suit was brought under the Convention on the Prevention and Punishment of the Crime of Genocide, adopted by the United Nations in 1948, in the aftermath of the atrocities committed during World War II. The Gambia and Myanmar are both parties to the Convention.
The Gambia’s Attorney General and Minister of Justice, Abubacarr Marie Tambadou, has been appointed as The Gambia’s Agent in the case. He stated that “The Gambia is taking this action to seek justice and accountability for the genocide being committed by Myanmar against the Rohingya, and to uphold and strengthen the global norm against genocide that is binding upon all States.” The suit has been fully endorsed by the OIC, an intergovernmental organization composed of States with large or majority Muslim populations. The OIC appointed The Gambia, an OIC member, to bring the case on its behalf.
The Gambia, in turn, chose Foley Hoag LLP to lead its legal team. Foley Hoag specializes in representing States before the International Court of Justice, and other international courts and arbitral tribunals. Paul Reichler, who heads Foley Hoag’s International Litigation and Arbitration practice and will serve as the team’s lead advocate, praised The Gambia for its “humanitarian concern for the survival of the Rohingya people, who face imminent extinction as a group, and its willingness to stand up and be counted in the struggle of all civilized nations to rid the world of genocide, the most heinous of all crimes against humanity.”
Other Foley Hoag attorneys on The Gambia’s team include partners Larry Martin and Andrew Loewenstein, counsel Arsalan Suleman, and associates Peter Tzeng, Yasmin Al Ameen, and Dario Maestro. Foley Hoag has also invited two prominent international lawyers and human rights experts, with whom it frequently collaborates, to serve as fellow advocates before the Court: Professor Philippe Sands of University College London, and Matrix Chambers; and Professor Payam Akhavan of McGill University in Montreal.
About Foley Hoag LLP
Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional senior level service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.
Foley Hoag LLP
+1 617 832 7010
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EET | Press release
HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme
Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EET | Press release
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants
Lionbridge Names Corinne Saunders as Managing Director, EMEA23.1.2020 21:00:00 EET | Press release
Today, Lionbridge, a global leader in localization and data training services, announced that former Wolters Kluwer executive Corinne Saunders has joined the company as managing director of EMEA. Lionbridge currently has 51 offices in 26 countries around the world; Saunders will oversee EMEA sales, account management, and marketing operations. “Europe represents a large portion of our overall business and will continue to be a growth area for our AI and localization businesses. I am very happy that Corinne is coming onboard to lead our efforts across EMEA,” says Lionbridge Chief Executive Officer John Fennelly. “Throughout her career, she’s shown an exceptional ability for driving innovation and understanding customer needs.” While at Wolters Kluwer, Saunders served as chief executive officer for emerging and developing markets. Saunders will work from Brussels, Belgium. About Lionbridge Lionbridge partners with brands to break barriers and build bridges all over the world. For more th
President Bill Clinton to Keynote 2020 World Patient Safety, Science & Technology Summit23.1.2020 20:34:00 EET | Press release
President Bill Clinton, the 42nd President of the United States, will be the closing keynote speaker at the Patient Safety Movement Foundation’s 2020 World Patient Safety, Science & Technology Summit. The 8th annual Summit will be held in Huntington Beach, California, beginning with a Pre-Summit Symposium on Thursday, March 5th. At the 2020 Summit, hospital leaders, medical and information technology innovators, patient advocates, policy makers and government officials collaborate and discuss best practices solutions to eliminate preventable patient deaths in hospitals around the world. The event is co-convened with the International Society for Quality in Health Care (ISQua), the American Society of Anesthesiologists and the European Society of Anaesthesiology. The 2020 Summit is scheduled for March 5 – 7th, 2020, at the Waterfront Beach Resort in Huntington Beach, California. For more information about the 2020 World Patient Safety, Science & Technology Summit, visit http://patientsa
Covantis initiative announces technology partner - ConsenSys23.1.2020 18:00:00 EET | Press release
The founding members of the Covantis initiative, which aims to modernize global trade operations, have announced the selection of ConsenSys, a market-leading Ethereum blockchain technology company, as the lead technology partner to develop its transformative platform. “The founders set up a robust selection process, including a two week hackathon, to ensure that we chose the right technology partner to meet our industry’s needs,” said Stefano Rettore, independent advisor to the project. “ConsenSys presented prototypes that demonstrated excellence in its field and has a track record of using blockchain technology to digitize processes in the commodity trade finance industry. We are confident this partnership will allow us to build a first-class product, centered around unparalleled functionality, security and privacy.” ConsenSys will leverage its enterprise-ready blockchain solutions and services, including PegaSys Orchestrate, Kaleido and MythX to build the blockchain network on Ethere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom